Related references
Note: Only part of the references are listed.
Article
Gastroenterology & Hepatology
Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease
B. Christensen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Letter
Gastroenterology & Hepatology
Vedolizumab in Inflammatory Bowel Disease Associated with Autoimmune Liver Disease Pre- and Postliver Transplantation: A Case Series
Tiong Yeng Lim et al.
INFLAMMATORY BOWEL DISEASES (2016)
Share Paper
